These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16113657)

  • 1. Opsoclonus myoclonus following allogeneic haematopoietic stem cell transplantation.
    Bishton MJ; Das Gupta E; Byrne JL; Russell NH
    Bone Marrow Transplant; 2005 Nov; 36(10):923. PubMed ID: 16113657
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk assessment in haematopoietic stem cell transplantation.
    Gratwohl A
    Best Pract Res Clin Haematol; 2007 Jun; 20(2):119-24. PubMed ID: 17448952
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term follow-up after reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia/myelodysplastic syndrome: late CNS relapses despite graft-versus-host disease.
    Davies JK; Taussig DC; Oakervee H; Davies AJ; Agrawal SG; Gribben JG; Lister TA; Cavenagh JD
    J Clin Oncol; 2006 May; 24(14):e23-5. PubMed ID: 16682729
    [No Abstract]   [Full Text] [Related]  

  • 4. Nonmyeloablative stem cell transplantation for myelodysplastic syndrome or acute myeloid leukemia in patients 60 years or older.
    Gupta V; Daly A; Lipton JH; Hasegawa W; Chun K; Kamel-Reid S; Tsang R; Yi QL; Minden M; Messner H; Kiss T
    Biol Blood Marrow Transplant; 2005 Oct; 11(10):764-72. PubMed ID: 16182177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myeloid leukemia in children: an evidence-based review.
    Oliansky DM; Rizzo JD; Aplan PD; Arceci RJ; Leone L; Ravindranath Y; Sanders JE; Smith FO; Wilmot F; McCarthy PL; Hahn T
    Biol Blood Marrow Transplant; 2007 Jan; 13(1):1-25. PubMed ID: 17222748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced-toxicity conditioning with treosulfan, fludarabine and ATG as preparative regimen for allogeneic stem cell transplantation (alloSCT) in elderly patients with secondary acute myeloid leukemia (sAML) or myelodysplastic syndrome (MDS).
    Kröger N; Shimoni A; Zabelina T; Schieder H; Panse J; Ayuk F; Wolschke C; Renges H; Dahlke J; Atanackovic D; Nagler A; Zander A
    Bone Marrow Transplant; 2006 Feb; 37(4):339-44. PubMed ID: 16415898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Paraneoplastic opsoclonus-myoclonus syndrome associated with small-cell lung cancer].
    Margery J; Ferroir JP; Epaud C; Martin C; Milleron B
    Rev Pneumol Clin; 2003 Nov; 59(5 Pt 1):321-4. PubMed ID: 14707930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic hematopoietic stem-cell transplantation in patients with acute myeloid leukemia in first complete remission: new answers for an old question.
    Shimoni A; Nagler A
    Leukemia; 2005 Jun; 19(6):891-3. PubMed ID: 15912143
    [No Abstract]   [Full Text] [Related]  

  • 9. An assessment of the RIFLE criteria for acute renal failure following myeloablative autologous and allogeneic haematopoietic cell transplantation.
    Lopes JA; Jorge S; Silva S; de Almeida E; Abreu F; Martins C; do Carmo JA; Lacerda JF; Prata MM
    Bone Marrow Transplant; 2006 Sep; 38(5):395. PubMed ID: 16915229
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute fulminant myocarditis after allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning for acute myelogenous leukemia.
    Nakaseko C; Sakaida E; Ohwada C; Ozawa S; Takeuchi M; Shimizu N; Cho R; Yokota A; Saito Y; Nishimura M
    Ann Hematol; 2007 Jan; 86(1):67-9. PubMed ID: 17021838
    [No Abstract]   [Full Text] [Related]  

  • 11. Metastatic gastric adenocarcinoma following allogeneic stem cell transplantation in a patient with acute myelogenous leukemia.
    Tsimberidou AM; Medina J; Earl M; Sierra M; Shriki JE; Bueso-Ramos C; Giralt S; Beran M; Giles FJ; Garcia-Manero G
    Bone Marrow Transplant; 2003 Mar; 31(5):413-4. PubMed ID: 12634736
    [No Abstract]   [Full Text] [Related]  

  • 12. Allogeneic hemopoietic stem cell transplants for patients with relapsed acute leukemia: long-term outcome.
    Bacigalupo A; Lamparelli T; Gualandi F; Occhini D; Bregante S; Raiola AM; Ibatici A; di Grazia C; Dominietto A; Piaggio G; Podesta M; Bruno B; Lombardi A; Frassoni F; Viscoli C; Sacchi N; Van Lint MT
    Bone Marrow Transplant; 2007 Mar; 39(6):341-6. PubMed ID: 17277788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An unusual cause of acute abdomen following allogeneic transplantation: a zoonotic disease revisited.
    Buyck HC; Holliman R; Else J; O'Regan L; Willis F; Grubnic S; Marsh J; Chakrabarti S
    Bone Marrow Transplant; 2008 Jun; 41(12):1069-70. PubMed ID: 18317455
    [No Abstract]   [Full Text] [Related]  

  • 14. Correction of celiac disease after allogeneic hematopoietic stem cell transplantation for acute myelogenous leukemia.
    Kline RM; Neudorf SM; Baron HI
    Pediatrics; 2007 Oct; 120(4):e1120-2. PubMed ID: 17893186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fludarabine and cytarabine combined chemotherapy followed by transfusion of donor blood stem cells for treating relapse of acute leukaemia after allogeneic haematopoietic stem cell transplantation.
    You Y; Li QB; Chen ZC; Li WM; Xia LH; Zhou H; Zou P
    Chin Med J (Engl); 2008 Sep; 121(18):1770-4. PubMed ID: 19080355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conditioning with fludarabine alone and allogeneic transplantation as a successful rescue therapy for persistent, severe iatrogenic aplasia after relapse of acute myeloid leukemia.
    Lazarevic V; Wahlin A
    Bone Marrow Transplant; 2007 Jan; 39(1):53-4. PubMed ID: 17115065
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk assessment in haemotopoietic stem cell transplantation: disease and disease stage.
    Chaidos A; Kanfer E; Apperley JF
    Best Pract Res Clin Haematol; 2007 Jun; 20(2):125-54. PubMed ID: 17448953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective multicenter trial of peripheral blood stem cell sibling allografts for acute myeloid leukemia in first complete remission using fludarabine-cyclophosphamide reduced intensity conditioning.
    Grigg AP; Gibson J; Bardy PG; Reynolds J; Shuttleworth P; Koelmeyer RL; Szer J; Roberts AW; To LB; Kennedy G; Bradstock KF
    Biol Blood Marrow Transplant; 2007 May; 13(5):560-7. PubMed ID: 17448915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma exchange for thrombotic thrombocytopenic purpura following hematopoietic stem cell transplantation.
    Sawant RB; Rajadhyaksha SB
    J Assoc Physicians India; 2005 Nov; 53():981-3. PubMed ID: 16515239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD34+ selected haematopoietic stem cell (HSC) not preceded by any immunosuppressive therapy as effective treatment for graft failure.
    Milone G; Tornello A; Leotta S; Poidomani M; Mercurio S; Farsaci B; Consoli C; Murgano P; Giustolisi R
    Bone Marrow Transplant; 2005 Mar; 35(5):521-2; author reply 522. PubMed ID: 15665846
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.